-
1 . Academic Journal
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
- 저자
- by Agajanian, Richy; Ahmad, Rizvana; Aktas, Bahriye; Alencar, Victor Hugo; Amadori, Dino, et al.
- 소스
- In The Lancet Oncology April 2020 21(4):519-530